Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexpanthenol and Hyaluronic Acid Eye Drops After Trans PRK
NCT06822608Phase 4Not yet recruiting
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexpanthenol in Corneal epithelial defect, sponsored by National and Kapodistrian University of Athens. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
dexpanthenol
03
Conditions
Corneal epithelial defect
Beyond the preview
Go deeper on NCT06822608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822608.